Skip to content
Catalyst

(R)-octopamineWhat was measured

Measured, with no finding

9 endpoints

Show what was measuredHide what was measured
  • circulating cortisol

    no effect, p = 0.05

    Substrate oxidation and circulating concentrations of free fatty acids, prolactin and cortisol were similar between trial conditions (all p>0.05)

    PMID 28389217 · one of two readings recorded this

  • circulating free fatty acids

    no effect, p = 0.05

    Substrate oxidation and circulating concentrations of free fatty acids, prolactin and cortisol were similar between trial conditions (all p>0.05)

    PMID 28389217 · one of two readings recorded this

  • circulating prolactin

    no effect, p = 0.05

    Substrate oxidation and circulating concentrations of free fatty acids, prolactin and cortisol were similar between trial conditions (all p>0.05)

    PMID 28389217 · one of two readings recorded this

  • heart rate during exercise

    no effect, p = 0.05

    There were also no differences across trials for heart rate or perceived exertion during exercise (both p>0.05)

    PMID 28389217 · one of two readings recorded this

  • perceived exertion during exercise

    no effect, p = 0.05

    There were also no differences across trials for heart rate or perceived exertion during exercise (both p>0.05)

    PMID 28389217 · one of two readings recorded this

  • substrate oxidation

    no effect, p = 0.05

    Substrate oxidation and circulating concentrations of free fatty acids, prolactin and cortisol were similar between trial conditions (all p>0.05)

    PMID 28389217 · one of two readings recorded this

  • work completed in 30 min performance task

    no effect, p = 0.38

    Performance was similar between the experimental trials (placebo: 352.8±39kJ; octopamine: 350.9±38.3kJ; Cohen's d effect size=0.05; p=0.380)

    PMID 28389217 · one of two readings recorded this

  • work completed (kJ) in a 30-min self-paced cycling performance task after 30 min at 55% peak power output

    no effect, placebo 352.8±39 kJ; octopamine 350.9±38.3 kJ; Cohen's d = 0.05, p = 0.38, n = 10

    Not recorded as a finding: this platform holds no node for the endpoint

    Performance was similar between the experimental trials (placebo: 352.8±39kJ; octopamine: 350.9±38.3kJ; Cohen's d effect size=0.05; p=0.380).

    PMID 28389217 · one of two readings recorded this

  • work completed (kJ) in a 30-minute cycling performance task after 30 min at 55% peak power output

    no effect, placebo 352.8 kJ vs octopamine 350.9 kJ; Cohen's d 0.05, p = 0.38, n = 10

    Not recorded as a finding: this platform holds no node for the endpoint

    Performance was similar between the experimental trials (placebo: 352.8±39kJ; octopamine: 350.9±38.3kJ; Cohen's d effect size=0.05; p=0.380).

    PMID 28389217 · one of two readings recorded this